UNSPSC 51162324: Acetaminophen/phenyltoloxamine/salicylamide

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162324 Acetaminophen/phenyltoloxamine/salicylamide is a Commodity code that in recent state and local solicitation activity covers the procurement of generic pharmaceutical and over-the-counter products, including naloxone and other multi-source medications, supplied through authorized wholesaler networks to government health and community facilities. State and local buyers under this code include county health departments, state cooperative purchasing alliances, and participating municipalities within multi-state frameworks. Seminole County, Florida and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represent the kinds of issuing bodies pursuing products tagged to this code—ranging from single-county health initiatives to regional cooperative purchasing vehicles that aggregate demand across multiple participating jurisdictions.

Recent activity shows geographic spread across Florida and the Upper Midwest, with MMCAP's RFP extending purchasing power to participating states including Oregon. Seminole County issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with a response deadline of July 26, 2023. MMCAP issued RFP S1070000015802 in January 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products, with questions due February 18, 2026, and proposals due March 26, 2026; awarded vendors were to be provided to authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health, and Morris & Dickson Co., LLC) by May 15, 2026, with contract effectiveness July 1, 2026. Both procurements emphasize compliance with FDA requirements, cGMP standards, and the Drug Supply Chain Security Act, with pricing evaluated on fixed costs, competitiveness, EDI capability, and wholesaler chargeback system integration.